SCOPUS 정보 검색 플랫폼

Volumn 7, Issue 6, 2001, Pages 1669-1675

Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer

(11) Birner, Peter a Oberhuber, Georg a Stani, Josephine a Reithofer, Cornelia a Kandioler Eckersberger, Daniela b Gnant, Michael b Jakesz, Raimund b Kubista, Ernst c Samonigg, Hellmut d Hausmaninger, Hubert e Kwasny, Werner e

a Institute for Clinical Pathology (Austria)

b Departments of Surgery (Austria)

c MEDICAL UNIVERSITY OF VIENNA (Austria)

d UNIVERSITY OF GRAZ (Austria)

e Department of Internal Medicine III ^* (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CB 11; ONCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOOD AND DRUG ADMINISTRATION; HERCEP TEST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; UNITED STATES;

ADULT; AGED; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MEDICAL ONCOLOGY; MIDDLE AGED; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; TIME FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0034900183 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (172)

References (23)

1
- 37049183697
- Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
- (1987) Science (Wash. DC) , vol.235 , pp. 177-182
- Slamon, D.J.¹ Clark, G.M.² Wong, S.G.³ Levin, W.J.⁴ Ullrich, A.⁵ McGuire, W.L.⁶

2
- 0024337144
- Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
- (1989) Science (Wash. DC) , vol.244 , pp. 707-712
- Slamon, D.J.¹ Godolphin, W.² Jones, L.A.³ Holt, J.A.⁴ Wong, S.G.⁵ Keith, D.E.⁶ Levin, W.J.⁷ Stuart, S.G.⁸ Udove, J.⁹ Ullrich, A.¹⁰

3
- 0032875086
- Evaluation of the HER-2/neu (erbB-2) status in breast cancer: From bench to bedside
- (1999) Mod. Pathol. , vol.12 , pp. 827-834
- Hanna, W.¹ Kahn, H.J.² Trudeau, M.³

4
- 0029591205
- C-erb-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer
- (1995) Eur. J. Cancer , vol.31 A , pp. 2185-2190
- Stal, O.¹ Sullivan, S.² Wingren, S.³ Skoog, L.⁴ Rutqvist, L.E.⁵ Carstensen, J.M.⁶ Nordenskjold, B.⁷

5
- 0028360192
- ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer
- (1994) Cancer Lett. , vol.81 , pp. 137-144
- Borg, A.¹ Baldetorp, B.² Ferno, M.³ Killander, D.⁴ Olsson, H.⁵ Ryden, S.⁶ Sigurdsson, H.⁷

6
- 0031930148
- HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: A Southwest Oncology Group Study
- (1998) Clin. Cancer Res. , vol.4 , pp. 7-12
- Elledge, R.M.¹ Green, S.² Ciocca, D.³ Pugh, R.⁴ Allred, D.C.⁵ Clark, G.M.⁶ Hill, J.⁷ Ravdin, P.⁸ O'Sullivan, J.⁹ Martino, S.¹⁰ Osborne, C.K.¹¹

7
- 0028354305
- C-erb-2 expression and response to adjuvant chemotherapy in women with node-positive early breast cancer
- (1994) N. Engl. J. Med. , vol.330 , pp. 1260-1266
- Muss, H.B.¹ Thor, A.D.² Berry, D.A.³ Kute, T.⁴ Liu, E.T.⁵ Koerner, F.⁶ Cirrincione, C.T.⁷ Budman, D.R.⁸ Wood, W.C.⁹ Barcos, M.¹⁰ Henderson, I.C.¹¹

8
- 0025177290
- Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: Prognostic significance of erbB-2 protein overexpression in primary breast cancer
- (1990) J. Clin. Oncol. , vol.8 , pp. 103-112
- Paik, S.¹ Hazan, R.² Fisher, E.R.³ Sass, R.E.⁴ Fisher, B.⁵ Redmond, C.⁶ Schlessinger, J.⁷ Lippman, M.E.⁸ King, C.R.⁹

9
- 0032850677
- Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER-2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease
- (1999) J. Clin. Oncol. , vol.17 , pp. 2639-2648
- Cobleigh, M.A.¹ Vogel, C.L.² Tripathy, D.³ Robert, N.J.⁴ Scholl, S.⁵ Fehrenbacher, L.⁶ Wolter, J.M.⁷ Paton, V.⁸ Shak, S.⁹ Lieberman, G.¹⁰ Slamon, D.J.¹¹

10
- 0031903646
- Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with her2/neu-overexpression metastatic breast cancer refractory to chemotherapy treatment
- (1998) J. Clin. Oncol. , vol.16 , pp. 2659-2671
- Pegram, M.D.¹ Lipton, A.² Hayes, D.F.³ Weber, B.L.⁴ Baselga, J.M.⁵ Tripathy, D.⁶ Baly, D.⁷ Baughman, S.A.⁸ Twaddell, T.⁹ Glaspy, J.A.¹⁰ Slamon, D.J.¹¹

11
- 0033764046
- An immunotherapeutic approach to treatment of breast cancer: Focus on trastuzumab plus paclitaxel
- Breast Cancer Medicine Service
- (2000) Cancer Chemother. Pharmacol. , vol.46 , pp. 23-26
- Gilewski, T.¹ Seidman, A.² Norton, L.³ Hudis, C.⁴

12
- 0032823487
- Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu overexpressing metastatic breast cancer
- (1999) Semin. Oncol. , vol.26 , pp. 78-83
- Baselga, J.M.¹ Tripathy, D.² Mendelsohn, J.³ Baughman, S.A.⁴ Benz, C.C.⁵ Dantis, L.⁶ Sklarin, N.T.⁷ Seidman, A.D.⁸ Hudis, C.A.⁹ Moore, J.¹⁰ Rosen, P.P.¹¹ Twaddell, T.¹² Henderson, I.C.¹³ Norton, L.¹⁴

13
- 0028232729
- Sensitivity of HER-2/neu antibodies in archival tissue samples: Potential source of error in immunohistochemical studies of oncogene expression
- (1994) Cancer Res. , vol.54 , pp. 2771-2777
- Press, M.F.¹ Hung, G.² Godolphin, W.³ Slamon, D.J.⁴

14
- 0032921406
- Increased HER2 with U.S. Food and Drug Administration-approved antibody
- (1999) J. Clin. Oncol. , vol.17 , pp. 434
- Roche, P.C.¹ Ingle, J.N.²

15
- 0033048939
- Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system
- (1999) J. Clin. Oncol. , vol.17 , pp. 1983-1987
- Jacobs, T.W.¹ Gown, A.M.² Yaziji, H.³ Barnes, M.J.⁴ Schnitt, S.J.⁵

16
- 0033055711
- The HercepTest assay: Another perspective
- (1999) J. Clin. Oncol. , vol.17 , pp. 2293-2294
- Espinoza, F.¹ Anguiano, A.²

17
- 0032440298
- Die therapiestudien der Austrian breast cancer Group (ABC)
- (1998) Zentralbl. Chir. , vol.123 , pp. 28-32
- Jakesz, R.¹ Hausmaninger, H.² Samonigg, H.³ Kubista, E.⁴ Haider, K.⁵ Mlineritsch, B.⁶ Schmid, M.⁷ Tausch, C.⁸ Reiner, G.⁹ Renner, K.¹⁰ Stierer, M.¹¹ Jatzko, G.¹² Hofbauer, F.¹³ Fridrik, M.¹⁴ Schennach, W.¹⁵ Sevelda, P.¹⁶ Dadak, C.¹⁷ Haid, A.¹⁸ Scholz, R.¹⁹ Lenzhofer, P.²⁰ more..

18
- 0033064336
- Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer
- (1999) J. Clin. Oncol. , vol.17 , pp. 1701-1709
- Jakesz, R.¹ Hausmaninger, H.² Haider, K.³ Kubista, E.⁴ Samonigg, H.⁵ Gnant, M.⁶ Manfreda, G.⁷ Tschurtschenthaler, G.⁸ Kolb, R.⁹ Stierer, M.¹⁰ Fridrik, M.¹¹ Mlineritsch, B.¹² Steindorfer, P.¹³ Mittlböck, M.¹⁴ Steger, G.¹⁵

19
- 0030763180
- Quantification of HER-2/neu amd c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization
- (1997) Mod. Pathol. , vol.10 , pp. 720-727
- Persons, D.L.¹ Borelli, K.A.² Hsu, P.H.³

20
- 33845382806
- Nonparametric estimation from incomplete observations
- (1985) J. Am. Stat. Assoc. , vol.53 , pp. 457-481
- Kaplan, E.L.¹ Meier, P.²

21
- 0026072872
- Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
- (1991) Histopathology , vol.19 , pp. 403-410
- Elston, C.W.¹ Ellis, I.O.²

22
- 0026718827
- ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization
- (2001) Proc. Natl. Acad. Sci. USA , vol.89 , pp. 5321-5325
- Kallioniemi, O.P.¹ Kallioniemi, A.² Kurisu, W.³ Thor, A.⁴ Chen, L.C.⁵ Smith, H.S.⁶ Waldman, F.M.⁷ Pinkel, D.⁸ Gray, J.W.⁹

23
- 0029884715
- Detection and quantification of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization
- (1996) Oncogene , vol.13 , pp. 63-72
- Pauletti, G.¹ Godolphin, W.² Press, M.F.³ Slamon, D.J.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.